---
schema_version: "secwatch.filing_event.v1"
accession: "0000929638-25-002133"
form_type: "8-K"
ticker: "ENGN"
cik: "0001980845"
company_name: "enGene Therapeutics Inc."
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-20T00:24:33.098173+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# enGene CMO Dr. Raj Pruthi resigns; effective June 16, 2025

## Summary
- Dr. Raj Pruthi resigned as Chief Medical Officer; resignation date June 3, 2025.
- He will support orderly transition of responsibilities before leaving on June 16, 2025.
- No successor named; responsibilities reallocated to other urology and clinical experts.

## SEC filing metadata
- accession: 0000929638-25-002133
- form_type: 8-K
- ticker: ENGN
- cik: 0001980845
- company_name: enGene Therapeutics Inc.
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1980845/000092963825002133/0000929638-25-002133-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1980845/000092963825002133/a8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000929638-25-002133
- JSON: https://secwatch.observer/filing/0000929638-25-002133.json
- Plain text: https://secwatch.observer/filing/0000929638-25-002133.txt

## Key facts
- Executive change
  Dr. Raj S. Pruthi resigned as Chief Medical Officer at enGene Therapeutics Inc..
  - Action: resigned
  - Role: Chief Medical Officer
  source text: On June 3, 2025, Dr. Raj S. Pruthi notified enGene Holdings Inc. (the “Company”) of his resignation from his position as Chief Medical Officer of the Company, with his resignation to be effective as of close of business on June 16, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1980845/000092963825002133/0000929638-25-002133-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.